KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Revenue

KYORIN Pharmaceutical had revenue of 33.73B JPY in the quarter ending December 31, 2025, a decrease of -1.24%. This brings the company's revenue in the last twelve months to 133.26B, up 9.63% year-over-year. In the fiscal year ending March 31, 2025, KYORIN Pharmaceutical had annual revenue of 130.09B with 8.83% growth.

• Revenue (ttm): 133.26B
• Revenue Growth: +9.63%
• P/S Ratio: 0.72
• Revenue / Employee: 66.70M
• Employees: 1,998
• Market Cap: 95.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	130.09B	10.56B	8.83%
Mar 31, 2024	119.53B	6.26B	5.53%
Mar 31, 2023	113.27B	7.74B	7.33%
Mar 31, 2022	105.53B	2.63B	2.56%
Mar 31, 2021	102.90B	-7.08B	-6.44%